Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model

SARS-CoV-2 causes devastating impact on the human population and has become a major public health concern. The frequent emergence of SARS-CoV-2 variants of concern urges the development of safe and efficacious vaccine against SARS-CoV-2 variants. We developed a candidate vaccine Baiya SARS-CoV-2 Vax...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugaraj, Balamurugan, Khorattanakulchai, Narach, Paungpin, Weena, Akkhawattanangkul, Yada, Manopwisedjaroen, Suwimon, Thitithanyanont, Arunee, Phoolcharoen, Waranyoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744481/
https://www.ncbi.nlm.nih.gov/pubmed/36533163
http://dx.doi.org/10.1016/j.btre.2022.e00779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744481/
https://www.ncbi.nlm.nih.gov/pubmed/36533163
http://dx.doi.org/10.1016/j.btre.2022.e00779

Ejemplares similares